Dec 16, 2019
MiMedx Announces Addition of Peter M. Carlson
Dec 12, 2019
MiMedx Provides Update Regarding Timing of Restatement
Sep 20, 2019
MiMedx Announces Resignation of Board Member
Aug 08, 2019
MiMedx Announces Agreement Regarding 2019 and 2020 Shareholder Meetings
Jun 17, 2019
MiMedx Shareholders Overwhelmingly Support Election of All Three of MiMedx's Highly Qualified Director Nominees
Jun 13, 2019
MiMedx Highlights Skills and Experience of Director Nominees
Jun 11, 2019
Leading Independent Proxy Advisory Firms ISS and Egan-Jones Recommend That MiMedx Shareholders Vote the BLUE Card "FOR" All Three of the Company's Director Nominees
Jun 10, 2019
MiMedx Issues Additional Information to Shareholders
Jun 07, 2019
MiMedx Urges Shareholders to Vote "FOR" All of the Board's Qualified Nominees on the BLUE Proxy Card
Jun 05, 2019
MiMedx Issues New Presentation for Investors in Advance of 2018 Annual Meeting
Jun 03, 2019
MiMedx Files Definitive Proxy Materials and Mails Letter to Shareholders
May 30, 2019
MiMedx Announces Comprehensive Board Refreshment Plan in Cooperation with Prescience Point
May 23, 2019
MiMedx Announces Conclusion of Audit Committee's Independent Investigation
May 09, 2019
MiMedx Appoints Timothy R. Wright as Chief Executive Officer
Apr 11, 2019
MiMedx Announces Board Approval of Long-Range Strategic Plan
Dec 05, 2018
MiMedx Announces Resignation Of Outside Auditor
Dec 05, 2018
MiMedx Announces Leadership Changes And Promotions
Dec 05, 2018
MiMedx Announces Organizational Realignment Program
Nov 07, 2018
MiMedx Receives Nasdaq Delisting Notification
Nov 07, 2018
MiMedx Adopts Limited Duration Shareholder Rights Plan In Response To Delisting From Nasdaq